Robert W. Perry
Robert W. Perry publishes mostly in Molecular Biology, Physiology and Neurology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Parkinson's Disease Mechanisms and Treatments.
- World rank
- #675,851 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #57,155 of 367,258
- Works
- 124
- Citations
- 6.7k
- Citations per work
- 54.0
What does Robert W. Perry research?
Robert W. Perry's work is mostly in Medicine (23%), Biochemistry, Genetics and Molecular Biology (11%), Neuroscience (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else7056.2%
- Health Sciences2822.9%
- Medicine2822.9%
- Life Sciences2620.9%
- Biochemistry, Genetics and Molecular Biology1310.6%
- Neuroscience1310.3%
- 1Molecular Biology11% of their works
- 2Physiology8% of their works
- 3Neurology8% of their works
- 4Psychiatry and Mental health7% of their works
- 5Cellular and Molecular Neuroscience6% of their works
- 6Neurology5% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Parkinson's Disease Mechanisms and Treatments
- Inflammatory Bowel Disease
- Nicotinic Acetylcholine Receptors Study
- Neuroscience and Neuropharmacology Research
- Cholinesterase and Neurodegenerative Diseases
- Neurological Disease Mechanisms and Treatments
Which keywords describe Robert W. Perry's research?
The keywords of their largest research topics: Oxidative Stress, Alzheimer's Disease, Neurodegeneration, Amyloid Hypothesis, Tau Pathology, Dementia, Mild Cognitive Impairment and a-Synuclein.
- Vascular Cognitive Impairment
- Cholinesterase Inhibitors
- Synaptic Plasticity
- Nicotinic Acetylcholine Receptors
- Crystal Structure
- a-Synuclein
- Neurodegenerative Diseases
- Dementia
- Amyloid Hypothesis
- Alzheimer's Disease
- Oxidative Stress
- Neurodegeneration
- Tau Pathology
- Mild Cognitive Impairment
- Parkinson's Disease
- Crohn's Disease
- Inflammatory Bowel Disease
- Neurotransmission
- Acetylcholinesterase
- Cerebral Hypoperfusion
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Oxidative Stress473 topics
- Alzheimer's Disease423 topics
- Neurodegeneration402 topics
- Amyloid Hypothesis251 topic
- Tau Pathology251 topic
- Dementia211 topic
- Mild Cognitive Impairment211 topic
- Neurodegenerative Diseases152 topics
- Parkinson's Disease151 topic
- a-Synuclein151 topic
- Crohn's Disease131 topic
- Crystal Structure131 topic
- Inflammatory Bowel Disease131 topic
- Nicotinic Acetylcholine Receptors131 topic
- Neurotransmission101 topic
- Synaptic Plasticity101 topic
- Acetylcholinesterase81 topic
- Cholinesterase Inhibitors81 topic
- Cerebral Hypoperfusion71 topic
- Vascular Cognitive Impairment71 topic
Where does Robert W. Perry work?
Robert W. Perry's main affiliation in the publication record is North Tyneside General Hospital, United Kingdom.
How many publications and citations does Robert W. Perry have?
OpenAlex counts 124 works and 6,700 citations for Robert W. Perry, an h-index of 39, ranking #675,851 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Robert W. Perry
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robert W. Perry. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.